Gans Ganapati, Co-Founder and Chief Business and Financial Officer of OrsoBio, brings over 25 years of business leadership experience. He was VP of Corporate Development and a member of the founding management team of Adamas Pharmaceuticals (Nasdaq: ADMS), where he was closely associated with the early development of Gocovri^® and the outlicensing of Namzaric^® to Forest Laboratories. Previously, he was a co-founder of HealthCare Global Enterprises (NSE:HCG), the largest provider of cancer care in India where he steered the company through multiple financings and IPO. He also served as founder and CEO of Triesta Sciences, an oncology CRO. Gans began his career in the M&A department of Credit Suisse First Boston in New York and Palo Alto. He received an MBA from the Wharton School of the University of Pennsylvania and is a graduate of the Indian Institute of Technology, Madras.